Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII

Thrombosis and Haemostasis

Volumn 77, Issue 5, 1997, Pages 926-933

  Geng, Jie Ping ^a   Castellino, Francis J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYGLUTAMIC ACID; BLOOD CLOTTING FACTOR 7; CALCIUM ION; CHIMERIC PROTEIN; COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; MUTANT PROTEIN; PROTEIN C; RECOMBINANT PROTEIN; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN;

ANTICOAGULATION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS;

EID: 0030988243     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656079     Document Type: Article

References (60)

1. Walker FJ. Regulation of activated protein C by a new protein. J Biol Chem 1980; 255: 5521-4.
2. Kisiel W, Canfield WM, Ericsson LH, Davie EW. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977; 16: 5824-31.
3. Vehar GA, Davie EW. Preparation and properties of bovine factor Vin (antihemophilic factor). Biochemistry 1980; 19: 401-10.
4. Amphlett GW, Kisiel W, Castellino FJ. Interaction of calcium with bovine plasma protein C. Biochemistry 1981; 20: 2156-61.
5. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-64.
6. Johnson AE, Esmon NL, Laue TM, Esmon CT. Structural changes required for activation of protein C are induced by Ca(II) binding to a high affinity site that does not contain γ-carboxyglutamic acid. J Biol Chem 1983; 258: 5554-60.
7. 2+-dependent conformational change required for activation by the thrombin-thrombomodulin complex. Biochemistry 1995; 34: 12221-6.
8. 2+-mediated binding to protein C. J Biol Chem 1991; 266: 19886-9.
9. Clarke JH, Light DR, Blasko E, Parkinson JF, Nagashima M, McLean K, Vilander L, Andrews JH. Morser J, Glaser CB. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. J Biol Chem 1993; 268: 6309-15.
10. Kisiel W, Ericsson LH, Davie EW. Proteolytic activation of protein C from bovine plasma. Biochemistry 1976: 15: 4893-900.
11. Beckmann RJ, Schmidt RJ, Santerre RF, Plutzky J, Crabtree GR, Long GL. The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs. Nucleic Acids Res 1985;13: 5233-47.
12. Zhang L. Castellino FJ. The contributions of individual gamma-carboxyglutamic acid residues in the calcium-dependent binding of recombinant human protein C to acidic phospholipid vesicles. J Biol Chem 1993; 268: 12040-5.
13. Christiansen WT, Geng JP, Castellino FJ. Structure-function assessment of the role of the helical stack domain in the properties of human recombinant protein C and activated protein C. Biochemistry 1995; 34: 8082-90.
14. Stern, DM, Nawroth PP, Kisiel W, Vehar G, Esmon CT. The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X. J Biol Chem 1985; 260: 6717-22.
15. Rimon S, Melamed R, Savion N, Scott T, Nawroth PP, Stern DM. Identification of a factor IX/IXa binding protein on the endothelial cell surface. J Biol Chem 1987; 262: 6023-31.
16. Ryan J, Huang LH, Tam JP, Wolitzky B, Heimer E, Lambrose T, Felix A, Nawroth P, Wilner G, Kisiel W, Nelsestuen GL. Stern DM. Structural determinants of the factor IX molecule mediating interaction with the endothelial cell binding site are distinct from those involved in phospholipid binding. J Biol Chem 1989; 264: 20283-7.
17. Cheung WF, Hamaguchi N, Smith KJ, Stafford DW. The binding of human factor IX to endothelial cells is mediated by residues 3-11. J Biol Chem 1992; 267: 20529-31.
18. Geng J-P, Christiansen WT, Plow EF, Castellino FJ. Transfer of specific endothelial cell-binding properties from the procoagulant protein human factor IX into the anticoagulant protein human protein C. Biochemistry 1995; 34: 8449-57.
19. Fukudome K, Esmon CT. Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR) - the structural and functional conservation in human, bovine, and murine EPCR. J Biol Chem 1995; 270: 5571-7.
20. Bangalore N, Drohan WN, Orthner CL. Characterization of the interaction between protein C (PC) and activated protein C (APC) with receptors on cultured umbilical vein endothelial cells (HUVEC). Thromb Haemost 1993; 69: 723.
21. Hancock WW, Grey ST, Hau L, Akalin E, Orthner C, Sayegh MH, Salem HH. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation 1995; 60: 1525-32.
22. Sakai T, Lund-Hansen T, Thim L, Kisiel W. The g-carboxyglutamic acid domain of human factor Vila is essential for its interaction with cell surface tissue factor. J Biol Chem 1990; 265: 1890-4.
23. Ruf W, Kalnik MW, Lund-Hansen T, Edgington TS. Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. J Biol Chem 1991; 266: 15719-25.
24. Toomey JR, Smith KJ, Stafford DW. Localization of the tissue factor recognition determinant of human factor VIIa. J Biol Chem 1991; 266: 19198-211.
25. Wildgoose P, Jorgensen T, Komiyama Y, Nakagaki T, Pedersen A, Kisiel W. The role of phospholipids and the factor VII gla-domain in the interaction of factor VII with tissue factor. Thromb Haemost 1992; 67: 679-85.
26. Chang JY, Stafford DW, Straight DL. The roles of factor VII's structural domains in tissue factor binding. Biochemistry 1995; 34: 12227-32.
27. Banner, DW, D'Arcy A. Chene C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y. Kirchofer D. The crystal structure of the complex of blood coagulation factor VII with soluble tissue factor. Nature 1996; 380: 41-6.
28. Zhang L, Castellino FJ. Influence of specific γ-carboxyglutamic acid residues on the integrity of the calcium-dependent conformation of human protein C. J Biol Chem 1992; 267: 26078-84.
29. Colpitts TL, Castellino FJ. Calcium and phospholipid binding properties of synthetic gamma-carboxyglutamic acid-containing peptides with sequence counterparts in human protein C. Biochemistry 1994: 33: 3501-8.
30. Yu S, Zhang L, Jhingan A, Christiansen WT, Castellino FJ. Construction, expression, and properties of a recombinant human protein C with replacement of its growth factor-like domains by those of human coagulation factor K. Biochemistry 1994: 33: 823-31.
31. Christiansen WT. Castellino FJ. Properties of recombinant chimeric human protein C and activated protein C containing the gamma-carboxyglutamic acid and trailing helical stack domains of protein C replaced by those of human coagulation factor IX. Biochemistry 1994; 33: 5901-11.
32. 7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry 1990; 29: 10828-34.
33. Amphlett GW, Byrne R, Castellino FJ. The binding of metal ions to bovine factor IX. J Biol Chem 1978; 253:6774-9.
34. Amphlett GW, Byrne R, Castellino FJ. The binding of calcium to the activation products of bovine factor IX. J Biol Chem 1979; 254: 6333-6.
35. Meyback B, Heim J, Rink H, Zimmermann W. Maerki W. Desulfatohirudin, a specific thrombin inhibitor: Expression and secretion in yeast. Thromb Res 1987; 7 (Suppl): 33.
36. Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, Chang RJ, Lin JH, Vilander L, Andrews WH, Light DR. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Invest 1992; 90: 2565-73.
37. Fisher KL, Gorman CM, Vehar GA, O'Brien D, Lawn RM. Cloning and expression of human tissue factor cDNA. Thromb Res 1987; 48: 89-99.
38. Heeb MJ, Schwartz P, White T, Lammle B, Berrettini M, Griffin J. Immunoblotting studies of the molecular forms of protein C in plasma. Thromb Res 1988; 52: 33-43.
39. Wakabayashi K, Sakata Y, Aoki N. Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C. J Biol Chem 1986; 261: 11097-105.
40. Foster DC, Davie EW. Characterization of a cDNA coding for human protein C. Proc Natl Acad Sci USA 1984; 81: 4766-70.
41. Hagen FS, Gray CL, O'Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986; 83: 2412-6.
42. Jhingan A, Zhang L, Christiansen WT, Castellino FJ. The activities of recombinant gamma-carboxyglutamic acid-deficient mutants of activated human protein C toward human coagulation factor VIII and factor Va in purified systems and in plasma. Biochemistry 1994; 33: 1869-75.
43. Clarke BJ, Ofosu FA, Sridhara S. Bona RD, Rickles FR, Blajchman MA. The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor. FEBS Lett 1992; 298: 206-10.
44. Menhart N, Sehl LC, Kelley RF, Castellino FJ. Construction, expression and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with ω-amino acids. Biochemistry 1991; 30: 1948-57.
45. De Serrano VS, Menhart N, Castellino FJ. The expression, purification and characterization of the recombinant kringle l domain from tissue-type plasminogen activator. Arch Biochem Biophys 1992; 294: 282-90.
46. De Serrano VS, Castellino FJ. The cationic locus on the recombinant kringle 2 domain of tissue-type plasminogen activator that stabilizes its interaction with ω-amino acids (1992) Biochemistry 1992; 31: 11698-706.
47. 1]plasminogen by tissue plasminogen activator and retards fibrin polymerization. Int J Peptide Protein Res 1990: 35: 73-80.
48. Yan SCB, Pazzano P, Chao YB, Walls JD, Berg DT, McClure DB, Grinnell BW. Characterization and novel purification of recombinant human protein C from three mammalian cell lines. Bio/technology 1990; 8: 655-61.
49. Geng JP, Cheng CH, Castellino FJ. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C. Thromb Haemost 1996: 76: 720-8.
50. Geng J-P, Castellino FJ. The propeptides of human protein C, factor VII, and factor IX are exchangeable with regard to directing gamma-carboxylation of these proteins. Thromb Haemost 1996; 76; 205-7.
51. 2+ ion and membrane binding structure of the gla-domain of Ca-prothrombin fragment 1. Biochemistry 1992; 31: 2554-66.
52. Zhang L, Castellino FJ. The binding energy of human coagulation protein C to acidic phospholipid vesicles contains a major contribution from leucine-5 in the gamma-carboxyglutamic acid domain. J Biol Chem 1994; 269: 3590-5.
53. Christiansen WT, Jalbert LR, Robertson RM, Jhingan A, Prorok M, Castellino FJ. Hydrophobic amino acid residues of human anticoagulation protein C that contribute to its functional binding to phospholipid vesicles. Biochemistry 1995; 34: 10376-82.
54. Jalbert LR, Chan JCY, Christiansen WT, Castellino FJ. The hydrophobic nature of residue-5 of human protein C is a major determinant of its functional interactions with acidic phospholipid vesicles. Biochemistry 1996; 35: 7093-9.
55. 2-terminal epidermal growth factor-like module of factor X. Effect of the gamma-carboxyglutamic acid-containing module. J Biol Chem 1993; 268: 26673-8.
56. Esmon NL, DeBault LE, Esmon CT. Proteolytic formation and properties of γ-carboxyglutamic acid-domainless protein C. J Biol Chem 1983; 258: 5548-53.
57. Lim TK, Bloomfield VA, Nelsestuen GL. Structure of the prothrombin-and blood clotting factor X-membrane complexes. Biochemistry 1977; 16: 4177-81.
58. Isaacs BS, Husten EJ, Esmon CT, Johnson AJ. A domain of membrane-bound blood coagulation factor Va is located far from the phospholipid surface. A fluorescence energy transfer measurement. Biochemistry 1986; 25: 4958-69.
59. Mutucumarana VP, Duffy EJ, Lollar P, Johnson AE. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor Villa. J Biol Chem 1992; 267: 17012-21.
60. Zhang L, Jhingan A, Castellino FJ. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood 1992; 80: 942-52.